Table 4.
Number of antihypertensive medications | ARPKD Subjects n (%) |
Controls n (%) |
P |
---|---|---|---|
All | |||
0 | 3 (14%) | 26 (59%) | < 0.0001 |
1 | 4 (18%) | 14 (32%) | |
2 or more | 15 (68%) | 4 (9%) | |
Excluding ACEi and ARB | |||
0 | 8 (36%) | 38 (86%) | < 0.0001 |
1 | 8 (36%) | 6 (14%) | |
2 or more | 6 (27%) | 0 (0%) |
ARPKD, autosomal recessive polycystic kidney disease; ACEi, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers